US Patent 8486414 Immunogenic compositions comprising
Patent 8486414 was granted and assigned to Infectious Disease Research Institute on July, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+325 characters)
Article
Patent abstract
The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infection.
Edits on 2 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Gregory C. Ireton0
Rhea N. Coler0
Steven G. Reed0
Sylvie Bertholet0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08486414 Immunogenic compositions comprising US Patent 8486414 Immunogenic compositions comprising
Infobox
Patent Number
084864140
Patent Number
84864140
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084864140
Date of Patent
July 16, 2013
0Patent Application Number
125948060
Date Filed
April 4, 2008
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08486414 Immunogenic compositions comprising
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08486414
Date of patent
July 16, 2013
Patent application number
12594806
Date Filed
April 4, 2008
Patent primary examiner
Find more entities like US Patent 8486414 Immunogenic compositions comprising
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
